Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Creative Medical Technology Holdings stock

CELZ
US22529Y2000
A2PZE4

Price

3.02
Today +/-
-0.07
Today %
-2.61 %
P

Creative Medical Technology Holdings stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Creative Medical Technology Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Creative Medical Technology Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Creative Medical Technology Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Creative Medical Technology Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Creative Medical Technology Holdings Stock Price History

DateCreative Medical Technology Holdings Price
10/1/20243.02 undefined
9/30/20243.10 undefined
9/27/20242.98 undefined
9/26/20243.02 undefined
9/25/20243.17 undefined
9/24/20243.09 undefined
9/23/20242.99 undefined
9/20/20243.12 undefined
9/19/20243.11 undefined
9/18/20243.25 undefined
9/17/20243.25 undefined
9/16/20243.39 undefined
9/13/20243.25 undefined
9/12/20243.02 undefined
9/11/20243.45 undefined
9/10/20243.37 undefined
9/9/20243.60 undefined
9/6/20243.31 undefined
9/5/20243.50 undefined
9/4/20243.51 undefined
9/3/20243.76 undefined

Creative Medical Technology Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Creative Medical Technology Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Creative Medical Technology Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Creative Medical Technology Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Creative Medical Technology Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Creative Medical Technology Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Creative Medical Technology Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Creative Medical Technology Holdings’s growth potential.

Creative Medical Technology Holdings Revenue, EBIT and net profit per share

DateCreative Medical Technology Holdings RevenueCreative Medical Technology Holdings EBITCreative Medical Technology Holdings Net Income
2029e82.79 M undefined0 undefined128.73 M undefined
2028e65.68 M undefined37.55 M undefined100.32 M undefined
2027e44.83 M undefined23.18 M undefined76.64 M undefined
2026e23.88 M undefined8.78 M undefined32 M undefined
2025e574,260 undefined-4.83 M undefined-37.03 M undefined
2024e0 undefined-5.04 M undefined-47.22 M undefined
20239,000 undefined-5.62 M undefined-5.29 M undefined
202290,000 undefined-10.24 M undefined-10.14 M undefined
202190,000 undefined-3.13 M undefined19.21 M undefined
2020160,000 undefined-1.11 M undefined-36.33 M undefined
2019170,000 undefined-1.13 M undefined-8.48 M undefined
2018120,000 undefined-1.12 M undefined-13.66 M undefined
20170 undefined-1.18 M undefined-2.66 M undefined
20160 undefined-760,000 undefined-770,000 undefined
20150 undefined-20,000 undefined-30,000 undefined
20140 undefined-20,000 undefined-30,000 undefined
20130 undefined-20,000 undefined-30,000 undefined
20120 undefined-20,000 undefined-30,000 undefined
20110 undefined-20,000 undefined-20,000 undefined
20100 undefined-20,000 undefined-20,000 undefined
20090 undefined-30,000 undefined-30,000 undefined
20080 undefined-50,000 undefined-50,000 undefined
20070 undefined-10,000 undefined-10,000 undefined
20060 undefined0 undefined0 undefined

Creative Medical Technology Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0000000000000000000023446582
---------------------91.3047.7326.15
------------------------
000000000000000000000000
00000000000-1-1-1-1-3-10-5-5-4823370
--------------------34.7852.2756.92-
00000000000-2-13-8-3619-10-5-47-373276100128
------------550.00-38.46350.00-152.78-152.63-50.00840.00-21.28-186.49137.5031.5828.00
000000000000000.060.321.091.41000000
------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Creative Medical Technology Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Creative Medical Technology Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (k)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (k)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (k)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (k)DEBT (M)TOTAL CAPITAL (M)
200620072008200920102011201220132014201520162017201820192020202120222023
                                   
00.02000000000.220.010.30.090.110.728.329.99
00000000000010100000
000000000000000000
00000000000000010106.59
00.010000000000000010.420.28
00.03000000000.220.010.310.10.110.7318.7510.27
000000000000000000
000000000000000000
000000000000000000
0000000000100180160440620530440441.01
000000000000000000
000000000000000003.28
0000000000100180160440620530440444.29
00.03000000000.320.190.470.540.7211.2619.1910.72
                                   
02020202020202020301101109002077010101.43
0.130.130.150.150.150.150.150.150.150.020.51.0712.1817.4721.3253.8869.6669.71
-0.11-0.12-0.17-0.2-0.22-0.24-0.27-0.3-0.330-0.77-3.43-17.08-25.57-61.89-43.67-53.81-59.1
000000000000000000
000000000000000000
0.020.03-0-0.03-0.05-0.07-0.1-0.13-0.160.05-0.16-2.25-4-8.08-39.810.2215.8610.61
0.010.010000.010.010.010.0100.070.240.330.320.350.763.270.32
000000000002020120160204039.92
00000000000.281.673.447.139.220.260.010.01
0000.030.050.070.090.120.1400.10.2501.060.79000
0000000000025068000000
0.010.0100.030.050.080.10.130.1500.452.434.478.640.521.043.320.37
0000000000300000000
000000000000000000
000000000000000000
0000000000300000000
0.010.0100.030.050.080.10.130.1500.482.434.478.640.521.043.320.37
0.030.04-0-0-00.01-00-0.010.050.320.180.470.520.7211.2619.1810.99
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Creative Medical Technology Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Creative Medical Technology Holdings's financial health and stability.

Assets

Creative Medical Technology Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Creative Medical Technology Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Creative Medical Technology Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Creative Medical Technology Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (k)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200620072008200920102011201220132014201520162017201820192020202120222023
00000000000-2-13-8-3619-10-5
000000000000000000
000000000000000000
00000000000000002-2
00000000000112735-2100
000000000000000000
000000000000000000
000000000000-1-10-2-7-8
000000000000000000
0000000000000000-103
0000000000000000-103
000000000000000000
0000000000001,0001,0000-1,00000
00000000000000015150
00000000000011012150
------------------
000000000000000000
00000000000000010-2-4
0-0.01-0.06-0.03-0.01-0.01-0.02-0.02-0.02-0.01-0.46-0.89-1.05-1.21-0.43-2.22-7.8-8.13
000000000000000000

Creative Medical Technology Holdings stock margins

The Creative Medical Technology Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Creative Medical Technology Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Creative Medical Technology Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Creative Medical Technology Holdings's sales revenue. A higher gross margin percentage indicates that the Creative Medical Technology Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Creative Medical Technology Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Creative Medical Technology Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Creative Medical Technology Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Creative Medical Technology Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Creative Medical Technology Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Creative Medical Technology Holdings Margin History

Creative Medical Technology Holdings Gross marginCreative Medical Technology Holdings Profit marginCreative Medical Technology Holdings EBIT marginCreative Medical Technology Holdings Profit margin
2029e60 %0 %155.49 %
2028e60 %57.17 %152.73 %
2027e60 %51.7 %170.95 %
2026e60 %36.78 %134.04 %
2025e60 %-841.56 %-6,447.85 %
2024e60 %0 %0 %
202360 %-62,445.89 %-58,739.67 %
202266.67 %-11,377.78 %-11,266.67 %
202144.44 %-3,477.78 %21,344.44 %
202068.75 %-693.75 %-22,706.25 %
201970.59 %-664.71 %-4,988.24 %
201841.67 %-933.33 %-11,383.33 %
201760 %0 %0 %
201660 %0 %0 %
201560 %0 %0 %
201460 %0 %0 %
201360 %0 %0 %
201260 %0 %0 %
201160 %0 %0 %
201060 %0 %0 %
200960 %0 %0 %
200860 %0 %0 %
200760 %0 %0 %
200660 %0 %0 %

Creative Medical Technology Holdings Stock Sales Revenue, EBIT, Earnings per Share

The Creative Medical Technology Holdings earnings per share therefore indicates how much revenue Creative Medical Technology Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Creative Medical Technology Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Creative Medical Technology Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Creative Medical Technology Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Creative Medical Technology Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Creative Medical Technology Holdings Revenue, EBIT and net profit per share

DateCreative Medical Technology Holdings Sales per ShareCreative Medical Technology Holdings EBIT per shareCreative Medical Technology Holdings Earnings per Share
2029e5.88 undefined0 undefined9.15 undefined
2028e4.67 undefined0 undefined7.13 undefined
2027e3.19 undefined0 undefined5.45 undefined
2026e1.7 undefined0 undefined2.27 undefined
2025e0.04 undefined0 undefined-2.63 undefined
2024e0 undefined0 undefined-3.36 undefined
20230.01 undefined-3.99 undefined-3.76 undefined
20220.08 undefined-9.39 undefined-9.3 undefined
20210.28 undefined-9.78 undefined60.03 undefined
20202.67 undefined-18.5 undefined-605.5 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined

Creative Medical Technology Holdings business model

Creative Medical Technology Holdings is an innovative biotech company specialized in the development and commercialization of medical devices and procedures for the diagnosis and treatment of diseases. The company was founded in 2010 by Dr. Thomas Ichim, an expert in regenerative medicine and tissue regeneration. Originally a startup, Creative Medical Technology has grown into a thriving biotech company in recent years. Its business model focuses on developing and marketing innovative medical devices and procedures to meet patient needs, with a particular focus on regenerative medicine, urological oncology, and sexual health. The company is divided into different divisions to concentrate on various medical areas. The regenerative medicine division develops products to promote tissue regeneration and wound healing, including the Plasmacure technology and AmnioStem product. The urological oncology division focuses on products for the diagnosis and treatment of urological diseases, particularly prostate cancer, with the HemaXellerate product being crucial. The sexual health division concentrates on products to improve sexual health and enhance libido, such as the Caverstem product. In total, Creative Medical Technology has developed several patented technologies that contribute to restoring health in various medical fields. The company collaborates closely with leading medical professionals to develop and improve its products. In conclusion, Creative Medical Technology is an innovative biotech company specialized in the development and commercialization of medical devices and procedures. It is divided into different divisions to focus on various medical areas and has already developed multiple technologies that contribute to restoring health. Creative Medical Technology Holdings is one of the most popular companies on Eulerpool.com.

Creative Medical Technology Holdings SWOT Analysis

Strengths

Creative Medical Technology Holdings Inc benefits from a highly skilled and experienced research and development team. This team possesses the necessary expertise to develop innovative medical technologies and solutions.

The company holds a robust intellectual property portfolio, consisting of patents, trademarks, and copyrights. This portfolio provides Creative Medical Technology Holdings Inc with a competitive advantage and protects their innovations from potential infringement.

Creative Medical Technology Holdings Inc has established valuable partnerships with key industry players. These strategic collaborations enhance the company's access to resources, expertise, and distribution channels, contributing to their growth and market reach.

Weaknesses

One of the weaknesses of Creative Medical Technology Holdings Inc is its dependence on external funding sources to support its research and development efforts. This reliance can introduce uncertainties and potential limitations in the company's ability to fund its operations.

Currently, Creative Medical Technology Holdings Inc has a limited market presence and brand recognition. This lack of visibility may impact the company's ability to attract partners, customers, and investors, hindering their growth potential.

Opportunities

With the growing demand for innovative medical technologies, Creative Medical Technology Holdings Inc has the opportunity to expand into new markets and reach a broader customer base. This expansion can lead to increased revenue and market share.

Advancements in technology offer Creative Medical Technology Holdings Inc the opportunity to develop more advanced and effective medical solutions. By staying up-to-date with the latest technological trends, the company can maintain its competitive edge and cater to evolving customer needs.

Threats

Creative Medical Technology Holdings Inc operates in a highly regulated industry. Any changes or additions to regulations can pose challenges for the company, potentially affecting their ability to bring new products and treatments to market.

The medical technology sector is highly competitive, with numerous companies vying for market share. Creative Medical Technology Holdings Inc faces the threat of intense competition, which can impact its ability to attract customers and maintain profitability.

Creative Medical Technology Holdings Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Creative Medical Technology Holdings historical P/E ratio, EBIT multiple, and P/S ratio

Creative Medical Technology Holdings shares outstanding

The number of shares was Creative Medical Technology Holdings in 2023 — This indicates how many shares 1.408 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Creative Medical Technology Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Creative Medical Technology Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Creative Medical Technology Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Creative Medical Technology Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Creative Medical Technology Holdings stock splits

In Creative Medical Technology Holdings's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Creative Medical Technology Holdings.

Creative Medical Technology Holdings latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.86 -1.11  (-29.55 %)2024 Q2
3/31/2024-1.17 -0.73  (37.77 %)2024 Q1
12/31/2023-1.15 -1.19  (-3.24 %)2023 Q4
9/30/2023-0.88 -1.02  (-16.28 %)2023 Q3
6/30/2023-0.85 -0.78  (7.87 %)2023 Q2
3/31/2023-1.02 -0.7  (31.37 %)2023 Q1
12/31/2022-0.71 -5.3  (-642.3 %)2022 Q4
9/30/2022-1.33 -0.7  (47.21 %)2022 Q3
6/30/2022-1.53 -2  (-30.72 %)2022 Q2
3/31/2022-1.43 -1.8  (-26.05 %)2022 Q1
1
2

Creative Medical Technology Holdings shareholders

%
Name
Stocks
Change
Date
0.16130 % Creative Medical Health, Inc.22,695010/30/2023
0.12529 % The Vanguard Group, Inc.17,629012/31/2023
0.08677 % Warbington (Timothy)12,209010/30/2023
0.05523 % Geode Capital Management, L.L.C.7,771-342/29/2024
0.01316 % Finger (Michael H.)1,851110/30/2023
0.00741 % UBS Financial Services, Inc.1,042-5012/31/2023
0.00642 % Tower Research Capital LLC903-52112/31/2023
0.00014 % Morgan Stanley Smith Barney LLC20012/31/2023
0.00008 % Wells Fargo Bank, N.A.11112/31/2023
0.00004 % Independent Financial Partners5012/31/2023
1
2
3
4

Creative Medical Technology Holdings Executives and Management Board

Mr. Timothy Warbington62
Creative Medical Technology Holdings President, Chief Executive Officer, Director (since 2016)
Compensation 469,224
Mr. Donald Dickerson58
Creative Medical Technology Holdings Chief Financial Officer, Senior Vice President, Director (since 2016)
Compensation 426,555
Ms. Susan Snow66
Creative Medical Technology Holdings Independent Director
Compensation 120,000
Mr. Bruce Urdang65
Creative Medical Technology Holdings Independent Director
Compensation 100,000
Mr. Michael Finger76
Creative Medical Technology Holdings Independent Director
Compensation 80,000
1

Most common questions regarding Creative Medical Technology Holdings

What values and corporate philosophy does Creative Medical Technology Holdings represent?

Creative Medical Technology Holdings Inc represents a commitment to innovation, excellence, and patient-centric healthcare. With a strong corporate philosophy focused on improving medical outcomes, Creative Medical Technology Holdings Inc aims to revolutionize the field of regenerative medicine. The company is dedicated to developing cutting-edge technologies and therapies that address the unmet needs of patients worldwide. By harnessing the power of stem cells and other advanced biological materials, Creative Medical Technology Holdings Inc strives to provide effective solutions for various medical conditions, promoting a healthier and better quality of life for individuals.

In which countries and regions is Creative Medical Technology Holdings primarily present?

Creative Medical Technology Holdings Inc is primarily present in the United States of America.

What significant milestones has the company Creative Medical Technology Holdings achieved?

Creative Medical Technology Holdings Inc has achieved significant milestones in their journey. The company has successfully developed innovative regenerative medical technologies and secured multiple patents in various fields, including reproductive medicine, immunology, and stem cell therapies. Additionally, Creative Medical Technology Holdings Inc has conducted successful clinical trials and collaborations with renowned medical institutions, further solidifying their position as a leading player in the regenerative medicine industry. The company's dedication to research and development, combined with their fruitful partnerships, has contributed to their notable achievements in advancing medical treatments and addressing unmet medical needs.

What is the history and background of the company Creative Medical Technology Holdings?

Creative Medical Technology Holdings Inc is a leading biotechnology company specializing in regenerative medicine. Established in [year], the company has a rich history of innovation and breakthroughs in the field. With a team of experienced scientists and researchers, Creative Medical Technology Holdings Inc focuses on developing cutting-edge therapies and treatments for various medical conditions. The company's commitment to improving patient outcomes through regenerative medicine has earned it a strong reputation in the industry. Leveraging its expertise and advanced technologies, Creative Medical Technology Holdings Inc continues to drive advancements in regenerative medicine, positioning itself as a leader in the field.

Who are the main competitors of Creative Medical Technology Holdings in the market?

The main competitors of Creative Medical Technology Holdings Inc in the market include companies such as Johnson & Johnson, Medtronic, Inc., Boston Scientific Corporation, Abbott Laboratories, and Stryker Corporation.

In which industries is Creative Medical Technology Holdings primarily active?

Creative Medical Technology Holdings Inc is primarily active in the healthcare industry.

What is the business model of Creative Medical Technology Holdings?

Creative Medical Technology Holdings Inc., a leading biotechnology company, focuses on developing innovative solutions in regenerative medicine. The company's business model revolves around identifying, acquiring, and advancing breakthrough technologies, aiming to improve patient outcomes and quality of life. With a strong emphasis on research and development, Creative Medical Technology Holdings Inc. collaborates with renowned experts and institutions in the field of regenerative medicine to bring cutting-edge therapeutic options to market. By harnessing the power of stem cells and other novel approaches, the company is dedicated to tackling some of the most challenging medical conditions and providing hope for patients worldwide.

What is the P/E ratio of Creative Medical Technology Holdings 2024?

The Creative Medical Technology Holdings P/E ratio is -0.09.

What is the P/S ratio of Creative Medical Technology Holdings 2024?

The Creative Medical Technology Holdings P/S ratio is 0.

What is the AlleAktien quality score of Creative Medical Technology Holdings?

The AlleAktien quality score for Creative Medical Technology Holdings is 4/10.

What is the revenue of Creative Medical Technology Holdings 2024?

The revenue cannot currently be calculated for Creative Medical Technology Holdings.

How high is the profit of Creative Medical Technology Holdings 2024?

The expected Creative Medical Technology Holdings profit is -47.22 M USD.

What is the business model of Creative Medical Technology Holdings

Creative Medical Technology Holdings Inc. (CMT) is a biological research company that focuses on innovative biotechnological solutions for unmet medical needs. The company is divided into several divisions that oversee different product lines and research projects. The main divisions of CMT are Regenerative Medicine, Stem Cell Research, Urology, and Oncology. The Regenerative Medicine division is CMT's flagship and focuses on researching and developing cellular therapies for tissue and organ restoration. An example of the product portfolio in this division is AmnioStem, a stem cell therapy derived from human placenta extract that can be used to support tissue regeneration. CMT's Stem Cell Research department utilizes innovative technologies to isolate, cultivate, and differentiate stem cells for medical research and therapy development. An example of the product portfolio in this division is Xenostem, a method for reprogramming pig stem cells for human use. CMT's Urology division specializes in developing products that facilitate the treatment of urinary tract and male reproductive system disorders. An example of the product portfolio in this division is ImmCelz, a product for modulating immunotherapy in patients with chronic interstitial cystitis. CMT's Oncology division specializes in researching new drugs for cancer treatment. An example of the product portfolio in this division is CMTC-Oncology, an innovative cancer drug derived from a plant extract. CMT collaborates closely with academic institutions and clinics to validate its research findings in preclinical and clinical trials. CMT's products are designed to meet the medical needs of people worldwide. CMT's business model is to leverage innovative technologies for developing therapies for unmet medical needs and market these therapies through licensing agreements or partnerships with pharmaceutical or biotechnology companies. CMT also works on developing its own medical products that are launched on the market through its own distribution network or partner companies. CMT also employs an aggressive IP strategy to ensure the protection of intellectual property rights for its products and technologies. This gives the company a clear competitive position in the market. CMT's goal is to make a significant contribution to improving the health and well-being of people worldwide by developing innovative biotechnological solutions for unmet medical needs.

What is the Creative Medical Technology Holdings dividend?

Creative Medical Technology Holdings pays a dividend of 0 USD distributed over payouts per year.

How often does Creative Medical Technology Holdings pay dividends?

The dividend cannot currently be calculated for Creative Medical Technology Holdings or the company does not pay out a dividend.

What is the Creative Medical Technology Holdings ISIN?

The ISIN of Creative Medical Technology Holdings is US22529Y2000.

What is the Creative Medical Technology Holdings WKN?

The WKN of Creative Medical Technology Holdings is A2PZE4.

What is the Creative Medical Technology Holdings ticker?

The ticker of Creative Medical Technology Holdings is CELZ.

How much dividend does Creative Medical Technology Holdings pay?

Over the past 12 months, Creative Medical Technology Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Creative Medical Technology Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Creative Medical Technology Holdings?

The current dividend yield of Creative Medical Technology Holdings is .

When does Creative Medical Technology Holdings pay dividends?

Creative Medical Technology Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Creative Medical Technology Holdings?

Creative Medical Technology Holdings paid dividends every year for the past 0 years.

What is the dividend of Creative Medical Technology Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Creative Medical Technology Holdings located?

Creative Medical Technology Holdings is assigned to the '-' sector.

Wann musste ich die Aktien von Creative Medical Technology Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Creative Medical Technology Holdings from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Creative Medical Technology Holdings pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Creative Medical Technology Holdings in the year 2023?

In the year 2023, Creative Medical Technology Holdings distributed 0 USD as dividends.

In which currency does Creative Medical Technology Holdings pay out the dividend?

The dividends of Creative Medical Technology Holdings are distributed in USD.

All fundamentals about Creative Medical Technology Holdings

Our stock analysis for Creative Medical Technology Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Creative Medical Technology Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.